Medical Cannabis for Insomnia
Quick Facts
Does medical cannabis improve sleep in people with insomnia?
The review, published October 13, assessed cannabis-based treatments against placebo or another medicine. Evidence certainty was low or very low, so the findings do not establish that every cannabis preparation is ineffective. They show that dependable treatment benefits remain unproven. [Cochrane review](https://www.cochrane.org/evidence/CD016216_what-are-benefits-and-risks-medical-cannabis-treating-insomnia-sleep-problems).
Trials were small, used different products and followed participants for limited periods. These differences make results difficult to compare and leave long-term benefits and harms unresolved. Reported adverse effects included dizziness and dry mouth; older adults and people with additional illnesses were inadequately represented. [Cochrane research summary](https://www.cochrane.org/about-us/news/insufficient-evidence-back-medical-cannabis-insomnia).
What treatment has stronger support for chronic insomnia?
CBT-I addresses thoughts and behaviors that perpetuate sleep difficulties. Treatment can combine strategies that strengthen the association between bed and sleep, adjust time spent in bed, reduce sleep-related worry and support relaxation. It is a structured treatment tailored to the individual. The American Academy of Sleep Medicine's guideline supports this approach for adults with chronic insomnia. [AASM clinical practice guideline](https://pmc.ncbi.nlm.nih.gov/articles/PMC7853203/).
Basic sleep advice alone is often insufficient: the guideline recommends against using sleep hygiene as the sole treatment. Access can include appointments in person, telehealth or suitable digital programs. For patients considering cannabis because other approaches have disappointed them, discussing access to structured CBT-I provides a practical next step. [AASM patient guide](https://aasm.org/wp-content/uploads/2021/08/Behavioral-and-Psychological-Treatments-for-Insomnia-Patient-Guide.pdf).
Frequently Asked Questions
No. Low-certainty evidence leaves uncertainty about benefits. The review does not establish which patients, products or doses might produce dependable improvements. [Cochrane review](https://www.cochrane.org/evidence/CD016216_what-are-benefits-and-risks-medical-cannabis-treating-insomnia-sleep-problems).
No. CBT-I combines behavioral and psychological treatment strategies. Sleep hygiene may form part of care, but the AASM advises against relying on it alone for chronic insomnia. [AASM guideline](https://pmc.ncbi.nlm.nih.gov/articles/PMC7853203/).
References
- Varela LB, et al. Medical cannabis for the treatment of insomnia. Cochrane Database of Systematic Reviews. 2026;10:CD016216. [Published review](https://doi.org/10.1002/14651858.CD016216.pub2).
- Cochrane. Insufficient evidence to back medical cannabis for insomnia. October 13, 2026. [Research summary](https://www.cochrane.org/about-us/news/insufficient-evidence-back-medical-cannabis-insomnia).
- Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255–262. [Clinical guideline](https://doi.org/10.5664/jcsm.8986).
- American Academy of Sleep Medicine. A patient's guide to understanding Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults. [Patient guide](https://aasm.org/wp-content/uploads/2021/08/Behavioral-and-Psychological-Treatments-for-Insomnia-Patient-Guide.pdf).